Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lalezari

Showing results (51-60 of 128) with videos related to

Pageof 13
Sort By:
Clinical and Diagnostic Laboratory Immunology|March 7, 2000
Transmission of human T-cell lymphotropic virus type 1 tax to rabbits by tax-only-positive human cellsD Zucker-Franklin, B A Pancake, P Lalezari, et al.
Vox Sanguinis|November 1, 1973
Anti-s and anti-U cold-reacting antibodiesP Lalezari, D C Malamut, M E Dreisiger, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
Structural abnormalities in the G-CSF receptor in severe congenital neutropeniaR V Deshpande, P Lalezari, R G Pergolizzi, et al.
Transfusion|March 1, 1972
Polybrene-induced red blood cell aggregation in vitro. Morphological aspectsH M Dembitzer, B J Oberhardt, J L Duffy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoproteinI Lalezari, S Rahbar, P Lalezari, et al.
Blood|November 1, 1992
O-linked oligosaccharides of glycophorins A and B in erythrocytes of two individuals with the Tn polyagglutinability syndromeO O Blumenfeld, P Lalezari, M Khorshidi, et al.
The American Journal of Medicine|November 1, 1980
Neutrophil kinetics in Felty's syndromeR A Joyce, D R Boggs, P A Chervenick, et al.
Vox Sanguinis|January 1, 1975
Development of direct antiglobulin reaction accompanying alloimmunization in a patient with Rhd (D, category III) phenotypeP Lalezari, N P Talleyrand, B Wenz, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2007
Preliminary safety and efficacy data of brecanavir, a novel HIV-1 protease inhibitor: 24 week data from study HPR10006Jacob P Lalezari, Douglas J Ward, Susan A Tomkins, et al.
AIDS (London, England)|October 9, 1998
Comparison of zidovudine phosphorylation in lymph nodes and peripheral blood mononuclear cells in HIV-infected patients. DATRI 012 Study GroupK Peter, J P Lalezari, J M Pearl, et al.
Pageof 13

Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Clinical and Diagnostic Laboratory Immunology|March 7, 2000
Transmission of human T-cell lymphotropic virus type 1 tax to rabbits by tax-only-positive human cellsD Zucker-Franklin, B A Pancake, P Lalezari, et al.
Vox Sanguinis|November 1, 1973
Anti-s and anti-U cold-reacting antibodiesP Lalezari, D C Malamut, M E Dreisiger, et al.
Journal of Hematotherapy & Stem Cell Research|January 14, 2000
Structural abnormalities in the G-CSF receptor in severe congenital neutropeniaR V Deshpande, P Lalezari, R G Pergolizzi, et al.
Transfusion|March 1, 1972
Polybrene-induced red blood cell aggregation in vitro. Morphological aspectsH M Dembitzer, B J Oberhardt, J L Duffy, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1988
LR16, a compound with potent effects on the oxygen affinity of hemoglobin, on blood cholesterol, and on low density lipoproteinI Lalezari, S Rahbar, P Lalezari, et al.
Blood|November 1, 1992
O-linked oligosaccharides of glycophorins A and B in erythrocytes of two individuals with the Tn polyagglutinability syndromeO O Blumenfeld, P Lalezari, M Khorshidi, et al.
The American Journal of Medicine|November 1, 1980
Neutrophil kinetics in Felty's syndromeR A Joyce, D R Boggs, P A Chervenick, et al.
Vox Sanguinis|January 1, 1975
Development of direct antiglobulin reaction accompanying alloimmunization in a patient with Rhd (D, category III) phenotypeP Lalezari, N P Talleyrand, B Wenz, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2007
Preliminary safety and efficacy data of brecanavir, a novel HIV-1 protease inhibitor: 24 week data from study HPR10006Jacob P Lalezari, Douglas J Ward, Susan A Tomkins, et al.
AIDS (London, England)|October 9, 1998
Comparison of zidovudine phosphorylation in lymph nodes and peripheral blood mononuclear cells in HIV-infected patients. DATRI 012 Study GroupK Peter, J P Lalezari, J M Pearl, et al.
Pageof 13